We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Single-Center Study Finds Bivalirudin Associated with Increased Ischemic Risk in Primary PCI for STEMI (HEAT PPCI).
- Authors
Cunningham, Muriel
- Abstract
This article presents results from the How Effective Are Antithrombotic Therapies in Primary Percutaneous Coronary Intervention trial [HEAT PPCI; NCT01519518]. All patients with ST-segment elevation myocardial infarction presenting at a single United Kingdom center were randomized to open-label treatment with heparin (70 units/kg body weight preprocedure) or bivalirudin (bolus of 0.75 mg/kg followed by 1.75 mg/kg/hour infusion during the procedure) on top of preprocedure dual antiplatelet therapy.
- Subjects
PRIMARY care; MYOCARDIAL infarction treatment; PLATELET aggregation inhibitors; HEPARIN; ABCIXIMAB (Drug); GLYCOPROTEINS
- Publication
MD Conference Express, 2014, Vol 14, Issue 4, p26
- ISSN
1559-8977
- Publication type
Article
- DOI
10.1177/155989771404016